心脏G蛋白偶联受体：健康心脏与衰竭心脏中的G蛋白偶联受体信号传导
Cardiac GPCRs: GPCR signaling in healthy and failing hearts.
作者信息
Salazar Natasha C, Chen Juhsien, Rockman Howard A
机构信息
Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
出版信息
Biochim Biophys Acta. 2007 Apr;1768(4):1006-18. doi: 10.1016/j.bbamem.2007.02.010. Epub 2007 Feb 20.
Abstract
G protein-coupled receptors (GPCRs) are widely implicated in human heart disease, making them an important target for cardiac drug therapy. The most commonly studied and clinically targeted cardiac GPCRs include the adrenergic, angiotensin, endothelin, and adenosine receptors. Treatment options focusing on the complex and integrated signaling pathways of these GPCRs are critical for the understanding and amelioration of heart disease. The focus of this review is to highlight the most commonly studied and clinically targeted cardiac GPCRs, placing emphasis on their common signaling components implicated in cardiac disease.
摘要
G蛋白偶联受体（GPCRs）与人类心脏病密切相关，使其成为心脏药物治疗的重要靶点。最常研究且临床上作为靶点的心脏GPCRs包括肾上腺素能受体、血管紧张素受体、内皮素受体和腺苷受体。针对这些GPCRs复杂且相互整合的信号通路的治疗方案对于理解和改善心脏病至关重要。本综述的重点是突出最常研究且临床上作为靶点的心脏GPCRs，着重介绍它们在心脏病中涉及的共同信号成分。
相似文献
1
Cardiac GPCRs: GPCR signaling in healthy and failing hearts.心脏G蛋白偶联受体：健康心脏与衰竭心脏中的G蛋白偶联受体信号传导
Biochim Biophys Acta. 2007 Apr;1768(4):1006-18. doi: 10.1016/j.bbamem.2007.02.010. Epub 2007 Feb 20.
2
Phosphorylation of G protein-coupled receptors: GPCR kinases in heart disease.G蛋白偶联受体的磷酸化：心脏病中的GPCR激酶
Mol Interv. 2003 Aug;3(5):264-72. doi: 10.1124/mi.3.5.264.
3
GPCR signaling and cardiac function.G蛋白偶联受体信号传导与心脏功能。
Eur J Pharmacol. 2015 Sep 15;763(Pt B):143-8. doi: 10.1016/j.ejphar.2015.05.019. Epub 2015 May 14.
4
The role of GPCR signaling in cardiac Epithelial to Mesenchymal Transformation (EMT).GPCR 信号在心脏上皮细胞向间充质转化（EMT）中的作用。
Trends Cardiovasc Med. 2019 May;29(4):200-204. doi: 10.1016/j.tcm.2018.08.007. Epub 2018 Aug 22.
5
G-protein coupled receptor signaling in myocardium: not for the faint of heart.心肌中的G蛋白偶联受体信号传导：并非胆小者可为。
Physiology (Bethesda). 2007 Jun;22:174-84. doi: 10.1152/physiol.00051.2006.
6
erbB2 is required for G protein-coupled receptor signaling in the heart.心脏中G蛋白偶联受体信号传导需要erbB2。
Proc Natl Acad Sci U S A. 2006 Oct 24;103(43):15889-93. doi: 10.1073/pnas.0607499103. Epub 2006 Oct 16.
7
G protein-coupled receptor signaling in cardiac nuclear membranes.心脏核膜中的G蛋白偶联受体信号传导
J Cardiovasc Pharmacol. 2015 Feb;65(2):101-9. doi: 10.1097/FJC.0000000000000196.
8
G-protein-coupled receptor expression, function, and signaling in macrophages.巨噬细胞中的G蛋白偶联受体表达、功能及信号传导
J Leukoc Biol. 2007 Jul;82(1):16-32. doi: 10.1189/jlb.0107051. Epub 2007 Apr 24.
9
Genetic manipulation of myocardial beta-adrenergic receptor activation and desensitization.心肌β-肾上腺素能受体激活与脱敏的基因操作
J Mol Cell Cardiol. 2004 Jul;37(1):11-21. doi: 10.1016/j.yjmcc.2004.03.014.
10
Adrenal G Protein-Coupled Receptors and the Failing Heart: A Long-distance, Yet Intimate Affair.肾上腺 G 蛋白偶联受体与衰竭心脏：一场漫长而又亲密的恋情。
J Cardiovasc Pharmacol. 2022 Sep 1;80(3):386-392. doi: 10.1097/FJC.0000000000001213.
引用本文的文献
1
The β-Adrenergic Receptor: Structure, Physiopathology of Disease, and Emerging Therapeutic Potential.β-肾上腺素能受体：结构、疾病的病理生理学及新兴治疗潜力
Adv Pharmacol Pharm Sci. 2024 Nov 28;2024:2005589. doi: 10.1155/2024/2005589. eCollection 2024.
2
The roles of G protein-coupled receptor kinase 2 in renal diseases.G 蛋白偶联受体激酶 2 在肾脏疾病中的作用。
J Cell Mol Med. 2024 Oct;28(20):e70154. doi: 10.1111/jcmm.70154.
3
Metabolite signaling in the heart.心脏中的代谢物信号传递。
Nat Cardiovasc Res. 2023 Jun;2(6):504-516. doi: 10.1038/s44161-023-00270-6. Epub 2023 May 25.
4
Hypertensive Heart Disease: Mechanisms, Diagnosis and Treatment.高血压性心脏病：机制、诊断与治疗
Rev Cardiovasc Med. 2024 Mar 6;25(3):93. doi: 10.31083/j.rcm2503093. eCollection 2024 Mar.
5
MEK inhibitors: a promising targeted therapy for cardiovascular disease.丝裂原活化蛋白激酶激酶（MEK）抑制剂：一种有前景的心血管疾病靶向治疗方法。
Front Cardiovasc Med. 2024 Jul 1;11:1404253. doi: 10.3389/fcvm.2024.1404253. eCollection 2024.
6
G Protein-Coupled Receptors: A Century of Research and Discovery.G 蛋白偶联受体：一个世纪的研究与发现。
Circ Res. 2024 Jun 21;135(1):174-197. doi: 10.1161/CIRCRESAHA.124.323067. Epub 2024 Jun 20.
7
Molecular Pathways and Animal Models of Cardiomyopathies.心肌疾病的分子途径和动物模型。
Adv Exp Med Biol. 2024;1441:991-1019. doi: 10.1007/978-3-031-44087-8_64.
8
Cardiomyocyte-specific overexpression of GPR22 ameliorates cardiac injury in mice with acute myocardial infarction.心肌细胞特异性过表达 GPR22 可改善急性心肌梗死小鼠的心脏损伤。
BMC Cardiovasc Disord. 2024 May 30;24(1):287. doi: 10.1186/s12872-024-03953-5.
9
Rules and mechanisms governing G protein coupling selectivity of GPCRs.G 蛋白偶联受体 G 蛋白偶联选择性的规则和机制。
Cell Rep. 2023 Oct 31;42(10):113173. doi: 10.1016/j.celrep.2023.113173. Epub 2023 Sep 23.
10
Estradiol mitigates stress-induced cardiac injury and inflammation by downregulating ADAM17 via the GPER-1/PI3K signaling pathway.雌二醇通过 GPER-1/PI3K 信号通路下调 ADAM17 减轻应激诱导的心脏损伤和炎症。
Cell Mol Life Sci. 2023 Aug 12;80(9):246. doi: 10.1007/s00018-023-04886-6.
本文引用的文献
1
Calmodulin kinase II inhibition protects against myocardial cell apoptosis in vivo.钙调蛋白激酶II抑制可在体内保护心肌细胞免于凋亡。
Am J Physiol Heart Circ Physiol. 2006 Dec;291(6):H3065-75. doi: 10.1152/ajpheart.00353.2006. Epub 2006 Jul 21.
2
Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction.间歇性压力过载引发非肥大性心脏功能障碍和血管稀疏。
J Clin Invest. 2006 Jun;116(6):1547-60. doi: 10.1172/JCI25397.
3
Role of beta-adrenergic receptor signaling and desensitization in heart failure: new concepts and prospects for treatment.β-肾上腺素能受体信号传导与脱敏在心力衰竭中的作用：治疗的新概念与前景
Expert Rev Cardiovasc Ther. 2006 May;4(3):417-32. doi: 10.1586/14779072.4.3.417.
4
Regulation of cardiac stress signaling by protein kinase d1.蛋白激酶D1对心脏应激信号的调节
Mol Cell Biol. 2006 May;26(10):3875-88. doi: 10.1128/MCB.26.10.3875-3888.2006.
5
Epsilon protein kinase C as a potential therapeutic target for the ischemic heart.ε蛋白激酶C作为缺血性心脏病的潜在治疗靶点。
Cardiovasc Res. 2006 May 1;70(2):222-30. doi: 10.1016/j.cardiores.2006.02.015. Epub 2006 Feb 23.
6
Alpha1-adrenergic receptors prevent a maladaptive cardiac response to pressure overload.α1肾上腺素能受体可防止心脏对压力超负荷产生适应性不良反应。
J Clin Invest. 2006 Apr;116(4):1005-15. doi: 10.1172/JCI22811.
7
A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy.人类磷酸受纳蛋白基因中的一个突变，删除了精氨酸14，会导致致命的遗传性心肌病。
Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1388-93. doi: 10.1073/pnas.0510519103. Epub 2006 Jan 23.
8
Mechanisms of Disease: ryanodine receptor defects in heart failure and fatal arrhythmia.疾病机制：心力衰竭和致命性心律失常中的兰尼碱受体缺陷
Nat Clin Pract Cardiovasc Med. 2006 Jan;3(1):43-52. doi: 10.1038/ncpcardio0419.
9
The L-type calcium channel in the heart: the beat goes on.心脏中的L型钙通道：搏动仍在继续。
J Clin Invest. 2005 Dec;115(12):3306-17. doi: 10.1172/JCI27167.
10
Long-term bradycardia caused by atrioventricular block can remodel the canine heart to detect the histamine H1 blocker terfenadine-induced torsades de pointes arrhythmias.房室传导阻滞引起的长期心动过缓可使犬心脏发生重塑，以检测组胺H1阻滞剂特非那定诱导的尖端扭转型室性心律失常。
Br J Pharmacol. 2006 Mar;147(6):634-41. doi: 10.1038/sj.bjp.0706493.
Zotero 插件